Target Outcomes in Psoriatic Arthritis: Simultaneous Achievement of ACR50-Psoriasis Area and Severity Index 100 and Beyond: Insights from Open-Label, Assessor-Blinded Study at Week 24

Smolen J, Behrens F, Liu-Leage S, Sapin C, De La Torre I, Meszaros G, Schett G, Gossec L, Ostor A, Combe B, Van Den Bosch F (2020)


Publication Type: Conference contribution

Publication year: 2020

Journal

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Smolen, J., Behrens, F., Liu-Leage, S., Sapin, C., De La Torre, I., Meszaros, G.,... Van Den Bosch, F. (2020). Target Outcomes in Psoriatic Arthritis: Simultaneous Achievement of ACR50-Psoriasis Area and Severity Index 100 and Beyond: Insights from Open-Label, Assessor-Blinded Study at Week 24. In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Smolen, Josef, et al. "Target Outcomes in Psoriatic Arthritis: Simultaneous Achievement of ACR50-Psoriasis Area and Severity Index 100 and Beyond: Insights from Open-Label, Assessor-Blinded Study at Week 24." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2020.

BibTeX: Download